The expression of RNF183 was found to be up-regulated in inflammatory bowel disease (a causative factor for CRC) and to activate the classical nuclear factor-kappaB (NF-κB) pathway [16–18]. This evidence concerns the gene NFKB1 and inflammatory bowel disease.